Does transcranial magnetic stimulation cause cognitive decline?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

TMS Does Not Cause Cognitive Decline

Based on the available evidence, transcranial magnetic stimulation (TMS) does not cause cognitive decline and is generally safe for cognitive function. In fact, the evidence suggests TMS may improve certain cognitive domains, particularly in populations with existing cognitive impairment.

Safety Profile for Cognitive Function

The research consistently demonstrates that TMS does not produce persistent negative effects on cognition:

  • No decline observed: Multiple systematic reviews and meta-analyses found no statistically significant deterioration in any cognitive domain with low-frequency (≤1 Hz) rTMS 1. Similarly, comprehensive cognitive testing before and after rTMS treatment in patients with major depressive disorder showed no decline in performance on any cognitive tests 2.

  • Early safety data confirmed: Evidence from 1991 already suggested that TMS exposure in clinical situations has no persistent effects on the EEG or cognitive function, though transient effects may occur 3.

  • Transient disruption vs. permanent damage: When TMS is used "online" (during cognitive tasks), it can temporarily disrupt specific cognitive processes at precise time points—this is intentional for research purposes and represents temporary interference, not damage. Meta-analysis of online rTMS showed that 10 Hz and 20 Hz stimulation disrupted accuracy and slowed reaction times during active stimulation, but these were immediate, task-specific effects, not lasting impairment 4.

Potential Cognitive Benefits

The evidence actually points toward cognitive enhancement rather than decline:

  • Global cognitive improvement: A 2023 meta-analysis of high-frequency rTMS targeted over the dorsolateral prefrontal cortex (DLPFC) in age-related neurodegenerative diseases showed significant improvement in global cognitive function with a large effect size (g = 1.39) 5.

  • Alzheimer's disease: Clinical trials of rTMS in mild to moderate Alzheimer's disease demonstrated improvements on validated cognitive measures (MMSE, CDR-SB, SIB, ADAS-Cog) with statistically significant differences versus sham, and some evidence of sustained benefit at follow-up 6.

  • Depression-related improvements: In patients with major depressive disorder, improvements in cognitive functioning (such as maze completion) were associated with reduction in depressive symptoms rather than direct TMS effects 2.

  • Processing speed in older adults: Preliminary evidence suggests acute increases in slow-wave activity through rTMS are associated with improved processing speed in older adults at risk for cognitive decline 7.

Important Caveats

Seizure risk in susceptible individuals: While TMS does not cause cognitive decline, it may cause seizures or enhance epileptiform abnormalities in circumstances of heightened susceptibility, though treated seizure patients are unlikely to experience seizures with TMS 3. This is a safety concern distinct from cognitive decline.

Mild transient side effects: Reported adverse effects are mild to moderate and include transient headache, scalp discomfort, pain, and fatigue—none of which represent cognitive impairment 6.

Study heterogeneity: The literature shows substantial variability in stimulation parameters (frequency, duration, target location, intensity), making it difficult to identify optimal protocols, but this heterogeneity has not revealed any consistent pattern of cognitive harm across any parameter set 1, 5, 6.

Clinical Bottom Line

You can reassure patients that TMS does not cause cognitive decline. The technique is generally safe for cognitive function, with no evidence of persistent negative effects. Any immediate disruption during stimulation is temporary and task-specific. The emerging evidence suggests TMS may actually offer cognitive benefits, particularly for individuals with existing cognitive impairment or neurodegenerative conditions, though optimal protocols remain under investigation.

References

Related Questions

In an older adult with typical Alzheimer-type dementia, can transcranial magnetic stimulation (TMS) provide cognitive benefit?
A patient hospitalized for pneumonia improved on IV vancomycin and piperacillin‑tazobactam (Zosyn). What oral antibiotic regimen should be prescribed at discharge to cover typical and atypical pathogens?
Are endobronchial coils appropriate for patients with collateral ventilation?
What is the optimal oral triple therapy regimen for a patient with glycated hemoglobin (HbA1c) of 12% and random blood glucose (RBG) of 290 mg/dL, and what additional agents should be considered?
How should metformin be combined with an SGLT2 inhibitor and a GLP‑1 receptor agonist in the management of type 2 diabetes?
What is the appropriate management for a 16-year-old male student who developed a 20-day pruritic erythematous macular rash on his extremities, dorsal surfaces, and chest after starting fluoxetine 45 days ago, with partial response to dimenhydrinate and loratadine and no systemic symptoms?
What is the recommended treatment for an adult with acute otitis media presenting with right ear pain, ipsilateral hemicranial pain, feverish sensation, irritative cough, occasional mucous expectoration, watery rhinorrhea, myalgia, asthenia, tonsillar exudates, and an erythematous tympanic membrane, without alarm signs?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.